Adia Nutrition Inc. Recaps Transformative 2025: Explosive Growth, Strategic Focus, and Path to Nasdaq Uplisting
Winter Park, Florida--(Newsfile Corp. - December 29, 2025) - Adia Nutrition Inc. (OTCQB: ADIA), a leader in regenerative medicine, stem cell therapies, and premium wellness solutions, today announced a year-end recap of its pivotal 2025 achievements. The company delivered remarkable financial performance, operational expansion, and strategic milestones, positioning itself for sustained growth and an anticipated Nasdaq uplisting. "2025 has been a defining year of execution and momentum for...
2025-12-29 9:00 AM EST
Adia Labs Launches Turnkey Clinic Model for Chiropractic Practices with BoldMD
Winter Park, Florida--(Newsfile Corp. - December 17, 2025) - Adia Labs, a division of Adia Nutrition Inc. (OTCQB: ADIA), today announced a strategic marketing partnership with BoldMD, a leading medical marketing and AI technology company focused on longevity and wellness. The partnership is designed to accelerate the nationwide expansion of Axia MD's innovative chiropractor-hosted pop-up longevity clinics. This collaboration builds on Adia Labs' recently announced partnership with Axia MD,...
2025-12-17 9:48 AM EST
Adia Nutrition Inc. Announces IRB Approval from BeyondBound for Adia Med's Autism Clinical Study
Winter Park, Florida--(Newsfile Corp. - December 15, 2025) - Adia Nutrition Inc. (OTCQB: ADIA), a leader in regenerative medicine through its Adia Med subsidiary, today announced that the independent Institutional Review Board (IRB) BeyondBound has approved the company's patent-pending clinical study protocol focused on Autism Spectrum Disorder (ASD). IRB Approval Email
2025-12-15 10:30 AM EST
Adia Nutrition Inc. Files SEC Form 10 as Strategic Step Toward Full Reporting Status
Winter Park, Florida--(Newsfile Corp. - December 8, 2025) - Adia Nutrition Inc. (OTCQB: ADIA), announced today that, with the assistance of Adia's Chief Financial Officer, and following review by the Company's auditing accountant, its Form 10 registration statement was prepared and submitted by Adia's corporate accountant and legal counsel to the U.S. Securities and Exchange Commission (SEC).
2025-12-08 9:00 AM EST
Adia Med Partners with America's #1 Health Talk Show Host, Dr. Asa Andrew, to Bring Breakthrough Stem Cell Therapies to the Spotlight
Winter Park, Florida--(Newsfile Corp. - December 1, 2025) - Adia Nutrition Inc. (OTCQB: ADIA), one of the nation's leaders in Stem Cell Technology is excited to announce a partnership with 3X Physician and Multi-Platform Media talk show personality Dr. Asa Andrew (known to his fans as Doctor Asa). Dr. Asa To view an enhanced version of this graphic, please visit:
2025-12-01 9:30 AM EST
ADIA Nutrition Submits Patent-Pending Autism Protocol for Independent IRB Review - Clinical Study Launch Nears
Winter Park, Florida--(Newsfile Corp. - November 24, 2025) - ADIA Nutrition, Inc. (OTCQB: ADIA) announced today that, following the independent Institutional Review Board's (IRB) acceptance of its initial draft protocol and invitation to submit a final version, the company has now officially delivered the complete, Patent-Pending regenerative protocol for pediatric Autism Spectrum Disorder (ASD) for full review and potential acceptance of oversight. This submission represents a pivotal...
2025-11-24 8:00 AM EST
ADIA Nutrition Inc. to Host Webinar on HSCT for MS and Autoimmune Conditions with HSCT Warriors
Winter Park, Florida--(Newsfile Corp. - November 19, 2025) - ADIA Nutrition, Inc. (OTCQB: ADIA) invites all shareholders, supporters, and potential investors to join a live webinar tomorrow, Thursday, November 20, 2025, at 6:30 PM EST, hosted by HSCT Warriors. HSCT Warriors To view an enhanced version of this graphic, please visit:
2025-11-19 9:30 AM EST
ADIA Nutrition Inc. Requests SIC Code Update to 2836 (Biological Products) with SEC and OTC Markets
Winter Park, Florida--(Newsfile Corp. - November 17, 2025) - ADIA Nutrition, Inc. (OTCQB: ADIA), a leader in regenerative medicine, today announced it has filed with the SEC to update its Standard Industrial Classification (SIC) code from 2834 (Pharmaceutical Preparations) to 2836 (Biological Products, Except Diagnostic) and with OTC Markets to update from 6719 (Holding Companies, N.E.C.) to 2836 (Biological Products, Except Diagnostic), accurately reflecting its core business of...
2025-11-17 8:00 AM EST
Adia Med Files Provisional Patent for Breakthrough Regenerative Medical Protocol
Winter Park, Florida--(Newsfile Corp. - November 12, 2025) - ADIA Nutrition, Inc. (OTCQB: ADIA), a leader in advanced regenerative health solutions, today announced the filing of a provisional patent application with the United States Patent and Trademark Office (USPTO) for a novel medical protocol designed to enhance regenerative outcomes. This Patent Pending innovation represents a significant advancement in ADIA's mission to deliver cutting-edge, science-backed therapies. The proprietary...
2025-11-12 9:15 AM EST
Game-Changing Alliance: Adia Labs and Axia
Winter Park, Florida--(Newsfile Corp. - November 10, 2025) - Adia Nutrition Inc. (OTCQB: ADIA), a leader in regenerative medicine and premium wellness solutions, today announced a strategic partnership between its research and development division, Adia Labs, and AxiaMD, a premier provider of nationwide physician oversight and compliance services for med spas, IV clinics, physician assistants, nurse practitioners, and wellness practices. Under the agreement, AxiaMD's extensive network of...
2025-11-10 9:00 AM EST
Adia Nutrition Inc. Announces Transformative 2025 Milestones and Strategic Progress Toward Nasdaq Uplisting
Winter Park, Florida--(Newsfile Corp. - November 5, 2025) - Adia Nutrition Inc. (OTCQB: ADIA), a leader in regenerative medicine and premium wellness solutions, today recaps its pivotal year-to-date achievements, marked by explosive revenue growth, strategic divestitures, and decisive steps toward full SEC reporting and a Nasdaq listing. 2025 Key Milestones Q3 Revenue Surges Over 200% Quarter-Over-Quarter: On October 8, preliminary results showed revenue growth exceeding 100%, followed by the...
2025-11-05 10:00 AM EST
Adia Nutrition Thrilled to Announce to Shareholders Early Q3 Financials Release and Remarkable 200%+ Revenue Growth
Winter Park, Florida--(Newsfile Corp. - October 28, 2025) - Adia Nutrition (OTCQB: ADIA) is thrilled to announce the early release of its Q3 financial results, a powerful testament to the exceptional organization and unwavering commitment of our dynamic team. By unveiling these results weeks ahead of schedule, Adia Nutrition reinforces its dedication to transparency, operational excellence, and industry leadership, while delivering a financial performance that redefines success. Adia...
2025-10-28 9:30 AM EDT
Adia Nutrition Inc. Appoints Dr. Evan Thomas, MD, PhD, to Drive Adia Med's Specialized Treatment Revolution
Winter Park, Florida--(Newsfile Corp. - October 21, 2025) - Adia Nutrition Inc. (OTCQB: ADIA) is excited to announce the appointment of Evan Thomas, MD, PhD, as an Independent Medical Director for its medical division, Adia Med. A renowned radiation oncologist and visionary, Dr. Thomas will oversee clinic practices, including the cutting-edge Autologous Hematopoietic Stem Cell Transplantation (AHSCT) program, finalizing protocols to prepare for patient intake once in-network provider status...
2025-10-21 9:00 AM EDT
Adia Nutrition Paves Way for Nasdaq and New Investors Through SEC Form 10 Submission
Winter Park, Florida--(Newsfile Corp. - October 14, 2025) - Adia Nutrition Inc. (OTCQB: ADIA) is thrilled to announce a major milestone in its growth journey. The Company has engaged an independent public accounting firm and securities counsel to prepare and file its Form 10 registration statement with the U.S. Securities and Exchange Commission (SEC). This filing marks a significant step beyond OTC reporting and positions Adia as a fully reporting public company under the Securities Exchange...
2025-10-14 9:00 AM EDT
Adia Nutrition Inc. Delivers Explosive Third Quarter Growth: Revenue Surges Over 100% from Prior Quarter, with Remarkable Profit Margin Exceeding 20%
Winter Park, Florida--(Newsfile Corp. - October 8, 2025) - Adia Nutrition Inc. (OTCQB: ADIA), a trailblazer in umbilical cord stem cells and exosome sales and therapies, today announced phenomenal preliminary financial results for the third quarter ended September 30, 2025. The company achieved a monumental revenue increase of more than 100% compared to the second quarter, while posting an extraordinary profit margin exceeding 20% for the quarter. This blockbuster performance cements Adia...
2025-10-08 8:30 AM EDT
Adia Nutrition Inc. Divests Biolete Coffee Subsidiary to Cement Factory LLC, Retains 18% Ownership to Support Strategic Focus on Regenerative Medicine and Medical Sales
Winter Park, Florida--(Newsfile Corp. - October 6, 2025) - Adia Nutrition Inc. (OTCQB: ADIA), an emerging leader in regenerative medicine and innovative healthcare solutions, today announced the sale of its Biolete coffee subsidiary to Cement Factory LLC, a dynamic consumer products firm led by key owners Jeff Sciullo and AJ Sims. Adia will retain an 18% ownership stake in Cement Factory LLC, ensuring continued alignment with Biolete's growth while enabling Adia to concentrate resources on...
2025-10-06 12:39 PM EDT
Adia Nutrition Expands Rapidly, Tripling Sales Force with Regional Teams to Fuel U.S. and Worldwide Growth
Winter Park, Florida--(Newsfile Corp. - September 9, 2025) - Adia Nutrition, Inc. (OTCQB: ADIA), an emerging leader in regenerative medicine, is excited to announce a rapid expansion of its sales operations by tripling its sales force and creating four specialized teams to accelerate growth and market reach for its innovative Adialabs products. This strategic restructuring divides sales operations into dedicated teams for the East Coast, West Coast, Central U.S., and a team focused on...
2025-09-09 8:30 AM EDT
Adia Nutrition Inc. Identifies Over 20 Million Potentially Improperly Issued Shares and Initiates Process to Return Shares to Treasury
Winter Park, Florida--(Newsfile Corp. - September 4, 2025) - Adia Nutrition Inc. (OTCQB: ADIA), a publicly traded company focused on advancing stem cell therapies for orthopedics, pain management, wound repair, and regenerative medicine, today announced that it has identified over 20 million shares that may have been improperly issued as part of an ongoing review of its historical share structure. This discovery comes from a comprehensive internal audit designed to strengthen the integrity...
2025-09-04 8:45 AM EDT
Adia Med Finalizing In-Network Access with the Nation's Largest Health Insurers Including Medicare, Medicaid, Humana, Cigna, and Florida Blue
Winter Park, Florida--(Newsfile Corp. - September 2, 2025) - Adia Nutrition Inc. (OTCQB: ADIA), a rising name in regenerative medicine, is thrilled to announce a transformative step toward expanding patient access to its innovative stem cell therapies. The company is finalizing in-network provider status with some of the nation's largest health insurance providers-Humana, Florida Blue, Cigna, Medicare, and Medicaid-positioning Adia to bring its advanced treatments to millions of patients....
2025-09-02 10:27 AM EDT
Adia Nutrition Joins PI Doctors Elite Community as Preferred Vendor Unlocking Access to a $50 Billion Personal Injury Care Market
Winter Park, Florida--(Newsfile Corp. - August 28, 2025) - Adia Nutrition Inc. (OTCQB: ADIA), a publicly traded company focused on regenerative medicine and personalized healthcare, announced that its laboratory division, Adia Labs, has been selected as a preferred vendor for the PI Doctors Elite Community. This national network includes over 4,000 personal injury physicians across various specialties, providing Adia Labs with access to a robust referral base serving injury patients...
2025-08-28 9:00 AM EDT